Dong-Keun Hyun

Dong-Keun Hyun

Auto-generated profile, based on publicly available information

Dong-Keun Hyun

Department of Neurosurgery, Inha University Hospital, Incheon, Korea

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Korean Journal of Neurotrauma
Verified
Journal Article
Open access
PDF file
JMJi Won Moon
Ji Won Moon
DHDong Keun Hyun
Dong Keun Hyun
Moon JW, et al. Korean J Neurotrauma. 2017 Apr;13(1):1-8. https://doi.org/10.13004/kjnt.2017.13.1.1

1 July 2024 in Journal of Korean Neurosurgical Society
Verified
Journal Article
Open access
PDF file
JBJin Woo Bae
Jin Woo Bae
DHDong Keun Hyun
Dong Keun Hyun
Endovascular thrombectomy (EVT) has been established as the standard of care in the treatment of acute ischemic stroke (AIS) based on landmark randomized controlled trials. Nevertheless, while the strict eligibility of EVT for AIS patients restrict the wide application of EVT, a considerable population still undergoes off-label EVT. Besides, it is important to acknowledge that recanalization is not achieved in approximately 20% of procedures, and more than 50% of patients who undergo EVT still do not experience a favorable outcome. This article reviews the brief history of EVT trials and recent progressions in the treatment of AIS, with focusing on the expanding eligibility criteria, new target for EVT, and the evolution of EVT techniques.

1 September 2021 in Journal of Korean Neurosurgical Society
Verified
Journal Article
Open access
PDF file
HKHyun Sik Kim
Hyun Sik Kim
BCByung Moon Cho
Byung Moon Cho
CYChan Jong Yoo
Chan Jong Yoo
DCDae Han Choi
Dae Han Choi
DHDong Keun Hyun
Dong Keun Hyun
ICIn Bok Chang
In Bok Chang
Objective : Endovascular treatment of intracranial aneurysms is challenging in case of wide-necked aneurysms because coils are prone to herniate into the parent artery, causing thromboembolic events or vessel occlusion. This study aims to compare long-term angiographic results of wide-necked aneurysms treated by stent-assisted, double-microcatheter, or single-microcatheter groups.Methods : Between January 2003 and October 2016, 108 aneurysms that were treated with endovascular coil embolization with a neck size wider than 4 mm and a follow-up period of more than 3 years were selected. We performed coil embolization with singlemicrocatheter, double-microcatheter, and stent-assisted techniques. Angiographic results were evaluated using the Raymond-Roy occlusion classification (RROC). All medical and angiographic records were reviewed retrospectively.Results : Clinical and angiographic analyses were conducted in 108 wide-necked aneurysms. The immediate post-procedural results revealed RROC class I (complete occlusion) in 66 cases (61.1%), class II (residual neck) in 36 cases (33.3%), and class III (residual sac) in six cases (5.6%). The final follow-up results revealed class I in 48 cases (44.4%), class II in 49 cases (45.4%), and class III in 11 cases (10.2%). Of a total of 45 (41.6%) radiologic recurrences, there were 21 cases (19.4%) of major recurrence that required additional treatment, and 24 cases (22.2%) of minor recurrence. The final follow-up angiographic results showed statistically significant differences between the stent-assisted group and the others (p<0.01).Conclusion : Long-term follow-up angiography demonstrated that the stent-assisted technique had a better complete occlusion rate than the other two techniques.

31 August 2023 in Advances in Therapy
Verified
Journal Article
Open access
PDF file
JOJaewon Oh
Jaewon Oh
WKWonho Kim
Wonho Kim
GKGee-Hee Kim
Gee-Hee Kim
HKHack-Lyoung Kim
Hack-Lyoung Kim
SPSang-Don Park
Sang-Don Park
RIRESOLVE-INT Investigators
RESOLVE-INT Investigators
Introduction Patients with hypertension and additional cardiovascular risk factors pose a challenge by requiring more intensive blood pressure (BP) control. Single-pill combination (SPC) therapy can benefit these patients by improving medication adherence. Methods This prospective, multicenter observational study assessed the real-world safety and effectiveness of an SPC containing olmesartan, amlodipine, and hydrochlorothiazide (O/A/H) in South Korean patients with hypertension and cardiovascular risk factors. BP control rates, defined as the percentage of patients achieving systolic BP (SBP) < 130 mmHg and diastolic BP (DBP) < 80 mmHg for intensive BP control, and < 140 mmHg and < 90 mmHg, respectively, for standard BP control, were investigated across various cardiovascular risk groups, along with changes in SBP and DBP from baseline to week 24. Results The most prevalent cardiovascular risk factor was age (≥ 45 years in men, ≥ 55 years in women, 86.1%), followed by cardiovascular diseases (64.4%), dyslipidemia (53.7%), body mass index ≥ 25 kg/m2 (53.5%), and diabetes mellitus (DM) (46.3%). Switching to O/A/H showed significant BP reduction, with a mean change of − 17.8 mmHg/− 9.3 mmHg in SBP/DBP within 4 weeks. The intensive BP control rate was 41.4% (95% confidence interval [CI] 39.5, 43.4), and the standard BP control rate was 73.3% (95% CI 71.5, 75.1), with better control rates in the risk age group (43.1% and 74.1%, respectively) and cardiovascular disease group (42.0% and 73.8%, respectively). The DM group had relatively lower control rates (37.5% for intensive control and 69.4% for standard control). Common adverse drug reactions included dizziness (2.91%), hypotension (1.51%), and headaches (0.70%). Conclusion The SPC therapy of O/A/H caused a rapid and sustained reduction in SBP/DBP in patients’ hypertension and additional cardiovascular risk factors. The therapy was safe and well tolerated. Study Registration Number KCT0003401 (https://cris.nih.go.kr/cris/search/detailSearch.do/20795).

1 January 2017 in Korean Journal of Neurotrauma
Verified
Journal Article
Open access
PDF file
JMJi Won Moon
Ji Won Moon
DHDong Keun Hyun
Dong Keun Hyun
Moon JW, et al. Korean J Neurotrauma. 2017 Oct;13(2):153-157. https://doi.org/10.13004/kjnt.2017.13.2.153

1 July 2020 in Journal of Korean Neurosurgical Society
Verified
Journal Article
Open access
PDF file
KJKwang Wook Jo
Kwang Wook Jo
HKHoon Kim
Hoon Kim
DYDo Sung Yoo
Do Sung Yoo
DHDong-Keun Hyun
Dong-Keun Hyun
JCJin Hwan Cheong
Jin Hwan Cheong
TKTaek Hyun Kwon
Taek Hyun Kwon
The purpose of this study is identify the operation status of the neurosurgical care units (NCUs) in neurosurgical residency training hospitals nationwide and determine needed changes by comparing findings with those obtained from the Korean Neurosurgical Society (KNS) and Korean Society of Neurointensive Care Medicine (KNIC) survey of 2010. This survey was conducted over 1 year in 86 neurosurgical residency training hospitals and two neurosurgery specialist hospitals and focused on the following areas : 1) the current status of the infrastructure and operating systems of NCUs in Korea, 2) barriers to installing neurointensivist team systems, 3) future roles of the KNS and KNIC, and 4) a handbook for physicians and practitioners in NCUs. We compared and analyzed the results of this survey with those from a KNIC survey of 2010. Seventy seven hospitals (87.5%) participated in the survey. Nineteen hospitals (24.7%) employed a neurointensivist or faculty member; Thirty seven hospitals (48.1%) reported high demand for neurointensivists, and 62 hospitals (80.5%) stated that the mandatory deployment of a neurointensivist improved the quality of patient care. Forty four hospitals (57.1%) believed that hiring neurointensivist would increase hospital costs, and in response to a question on potential earnings declines. In terms of potential solutions to these problems, 70 respondents (90.9%) maintained that additional fees were necessary for neurointensivists' work, and 64 (83.1%) answered that direct support was needed of the personnel expenses for neurointensivists. We hope the results of this survey will guide successful implementation of neurointensivist systems across Korea.